Literature DB >> 23177341

[Variations of the hepatic SUV in relation to the body mass index in whole body PET-CT studies].

S M Batallés1, R L Villavicencio, A Quaranta, L Burgos, S Trezzo, R Staffieri, S M Pezzotto.   

Abstract

OBJECTIVE: To evaluate SUV changes in the liver in relation to body mass index (BMI) of patients who undergo whole body PET-CT scans.
MATERIAL AND METHODS: A retrospective study was performed. The variables studied were injected dose of (18F)FDG (mCi), age (years), blood glucose level (mg/dL), height (cm) and weight (kg). BMI was calculated and the SUV mean value was expressed according to gender and BMI. A linear regression analysis was applied to identify the independent variables that best predict the SUV value.
RESULTS: Six hundred and three patients were studied (305 women, 298 men; mean age: 54.9±15.2 years old). Mean SUV measurement was significantly higher in males than females and increased significantly both in male and female patients who were overweight and even more in obese patients. The independent variables that best predicted the SUV value were gender, age, and BMI. In those patients having similar characteristics related to the analyzed variables, the SUV value increased by 0.002 for each increase in one year, and by 0.066 per unit increase in the BMI value.
CONCLUSIONS: Hepatic uptake of (18F)FDG increases according to the patient's BMI. The independent variables that best predict the hepatic SUV value are age and sex of patients. Our findings show that the practice of using the physiological hepatic metabolic activity level as a reference regarding questionable deposits elsewhere in the abdomen and pelvis is not useful, at least in male patients with overweightness and obesity.
Copyright © 2011 Elsevier España, S.L. and SEMNIM. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23177341     DOI: 10.1016/j.remn.2012.02.003

Source DB:  PubMed          Journal:  Rev Esp Med Nucl Imagen Mol        ISSN: 2253-654X            Impact factor:   1.359


  5 in total

1.  Factors affecting intrapatient liver and mediastinal blood pool ¹⁸F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin's lymphoma.

Authors:  Agostino Chiaravalloti; Roberta Danieli; Paolo Abbatiello; Barbara Di Pietro; Laura Travascio; Maria Cantonetti; Manlio Guazzaroni; Antonio Orlacchio; Giovanni Simonetti; Orazio Schillaci
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-22       Impact factor: 9.236

2.  Semiquantitative Parameters in PSMA-Targeted PET Imaging with 18F-DCFPyL: Variability in Normal-Organ Uptake.

Authors:  Xin Li; Steven P Rowe; Jeffrey P Leal; Michael A Gorin; Mohamad E Allaf; Ashley E Ross; Kenneth J Pienta; Martin A Lodge; Martin G Pomper
Journal:  J Nucl Med       Date:  2016-12-08       Impact factor: 10.057

3.  Impacts of biological and procedural factors on semiquantification uptake value of liver in fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging.

Authors:  Mohd Hafizi Mahmud; Abdul Jalil Nordin; Fathinul Fikri Ahmad Saad; Ahmad Zaid Fattah Azman
Journal:  Quant Imaging Med Surg       Date:  2015-10

4.  Age-related changes of standardized uptake values in the blood pool and liver: a decade-long retrospective study of the outcomes of 2,526 subjects.

Authors:  Yuan Cao; Ke Zhou; Wei Diao; Xipeng Long; Fangfang Tian; Minggang Su; Zhiyun Jia
Journal:  Quant Imaging Med Surg       Date:  2021-01

5.  The appropriate whole body metric for calculating standardised uptake value and the influence of sex.

Authors:  Georgia Keramida; A Michael Peters
Journal:  Nucl Med Commun       Date:  2019-01       Impact factor: 1.690

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.